| 1 | Iron metabolism and iron disorders revisited in the hepcidin… (10.3324/haematol.2019.232124) | Abstract References ORCID License | 280.55 | 638 |
| 2 | The risk of recurrent venous thromboembolism after discontin… (10.3324/haematol.10516) | Abstract References ORCID License | 279.93 | 629 |
| 3 | ECIL-6 guidelines for the treatment of invasive candidiasis,… (10.3324/haematol.2016.152900) | Abstract References ORCID License | 275.66 | 570 |
| 4 | European guidelines for empirical antibacterial therapy for… (10.3324/haematol.2013.091025) | Abstract References ORCID License | 271.60 | 519 |
| 5 | Multiple myeloma and infections: a population-based study on… (10.3324/haematol.2014.107714) | Abstract References ORCID License | 264.84 | 444 |
| 6 | Report of the European Myeloma Network on multiparametric fl… (10.3324/haematol.11080) | Abstract References ORCID License | 261.70 | 413 |
| 7 | Toxicities and outcomes of 616 ibrutinib-treated patients in… (10.3324/haematol.2017.182907) | Abstract References ORCID License | 261.70 | 413 |
| 8 | The regulation and function of CD20: an “enigma” of B-cell b… (10.3324/haematol.2019.243543) | Abstract References ORCID License | 259.77 | 395 |
| 9 | Blast-derived microvesicles in sera from patients with acute… (10.3324/haematol.2010.039743) | Abstract References ORCID License | 258.55 | 384 |
| 10 | Survival for older patients with acute myeloid leukemia: a p… (10.3324/haematol.2012.066100) | Abstract References ORCID License | 256.58 | 367 |
| 11 | Management of Epstein-Barr Virus infections and post-transpl… (10.3324/haematol.2016.144428) | Abstract References ORCID License | 255.87 | 361 |
| 12 | Thrombopoietin receptor agonists: ten years later (10.3324/haematol.2018.212845) | Abstract References ORCID License | 255.63 | 359 |
| 13 | Cancer in the National Cancer Institute inherited bone marro… (10.3324/haematol.2017.178111) | Abstract References ORCID License | 253.78 | 344 |
| 14 | Correlation of high numbers of intratumoral FOXP3+ regulator… (10.3324/haematol.11702) | Abstract References ORCID License | 253.40 | 341 |
| 15 | Platelet receptors and signaling in the dynamics of thrombus… (10.3324/haematol.2008.003178) | Abstract References ORCID License | 252.76 | 336 |
| 16 | Gemtuzumab ozogamicin for <i>de novo</i> acute myeloid leuke… (10.3324/haematol.2018.188888) | Abstract References ORCID License | 252.63 | 335 |
| 17 | Extramedullary disease portends poor prognosis in multiple m… (10.3324/haematol.2012.065698) | Abstract References ORCID License | 252.50 | 334 |
| 18 | International recommendations on the diagnosis and treatment… (10.3324/haematol.2019.230771) | Abstract References ORCID License | 252.37 | 333 |
| 19 | International recommendations on the diagnosis and treatment… (10.3324/haematol.2008.001743) | Abstract References ORCID License | 251.98 | 330 |
| 20 | Hematopoietic stem cell transplantation in thalassemia major… (10.3324/haematol.2013.099747) | Abstract References ORCID License | 251.45 | 326 |
| 21 | PIM serine/threonine kinases in the pathogenesis and therapy… (10.3324/haematol.2009.017079) | Abstract References ORCID License | 250.92 | 322 |
| 22 | Diagnostic criteria for hematopoietic stem cell transplant-a… (10.3324/haematol.10699) | Abstract References ORCID License | 250.79 | 321 |
| 23 | SOX11 expression is highly specific for mantle cell lymphoma… (10.3324/haematol.2009.010264) | Abstract References ORCID License | 250.79 | 321 |
| 24 | Management of adults and children undergoing chimeric antige… (10.3324/haematol.2019.229781) | Abstract References ORCID License | 250.79 | 321 |
| 25 | European Myeloma Network Guidelines for the Management of Mu… (10.3324/haematol.2014.117176) | Abstract References ORCID License | 249.14 | 309 |
| 26 | Prediction of molecular subtypes in acute myeloid leukemia b… (10.3324/haematol.13299) | Abstract References ORCID License | 248.71 | 306 |
| 27 | A prospective comparison of 18F-fluorodeoxyglucose positron… (10.3324/haematol.10554) | Abstract References ORCID License | 248.57 | 305 |
| 28 | Integrated safety profile of single-agent carfilzomib: exper… (10.3324/haematol.2013.089334) | Abstract References ORCID License | 248.43 | 304 |
| 29 | Liver iron concentrations and urinary hepcidin in -thalasse… (10.3324/haematol.10842) | Abstract References ORCID License | 247.86 | 300 |
| 30 | Autologous hematopoietic stem cell transplantation for autoi… (10.3324/haematol.2009.013458) | Abstract References ORCID License | 247.86 | 300 |
| 31 | Diagnosis and treatment of mucormycosis in patients with hem… (10.3324/haematol.2012.065110) | Abstract References ORCID License | 247.71 | 299 |
| 32 | The Khorana score for prediction of venous thromboembolism i… (10.3324/haematol.2018.209114) | Abstract References ORCID License | 247.57 | 298 |
| 33 | Recurrent thrombosis in patients with polycythemia vera and… (10.3324/haematol.12053) | Abstract References ORCID License | 247.42 | 297 |
| 34 | Clinical outcomes in children with sickle cell disease livin… (10.3324/haematol.10937) | Abstract References ORCID License | 247.28 | 296 |
| 35 | Generation of CD4+ or CD8+ regulatory T cells upon mesenchym… (10.3324/haematol.11240) | Abstract References ORCID License | 246.83 | 293 |
| 36 | Blastic plasmacytoid dendritic cell neoplasm with leukemic p… (10.3324/haematol.2012.072645) | Abstract References ORCID License | 246.54 | 291 |
| 37 | Long-term risks after splenectomy among 8,149 cancer-free Am… (10.3324/haematol.2013.092460) | Abstract References ORCID License | 245.64 | 285 |
| 38 | Isolation of functionally distinct mesenchymal stem cell sub… (10.3324/haematol.13740) | Abstract References ORCID License | 245.02 | 281 |
| 39 | Regulation of CXCR4 expression in human mesenchymal stem cel… (10.3324/haematol.10669) | Abstract References ORCID License | 244.40 | 277 |
| 40 | Mesenchymal stem cells: the fibroblasts' new clothes? (10.3324/haematol.13699) | Abstract References ORCID License | 244.25 | 276 |
| 41 | High D-dimer levels are associated with poor prognosis in ca… (10.3324/haematol.2011.054718) | Abstract References ORCID License | 243.62 | 272 |
| 42 | Outcome of patients with acquired aplastic anemia given firs… (10.3324/haematol.10075) | Abstract References ORCID License | 242.98 | 268 |
| 43 | Non-transfusion-dependent thalassemias (10.3324/haematol.2012.066845) | Abstract References ORCID License | 242.98 | 268 |
| 44 | Report from the European Myeloma Network on interphase FISH… (10.3324/haematol.2011.056176) | Abstract References ORCID License | 242.49 | 265 |
| 45 | No alloantibodies against mesenchymal stromal cells, but pre… (10.3324/haematol.11446) | Abstract References ORCID License | 242.32 | 264 |
| 46 | Polarization dictates iron handling by inflammatory and alte… (10.3324/haematol.2010.023879) | Abstract References ORCID License | 242.16 | 263 |
| 47 | Diagnosis and classification of myelodysplastic syndrome: In… (10.3324/haematol.13405) | Abstract References ORCID License | 241.83 | 261 |
| 48 | BLUEPRINT: mapping human blood cell epigenomes (10.3324/haematol.2013.094243) | Abstract References ORCID License | 241.66 | 260 |
| 49 | The molecular biology of mixed lineage leukemia (10.3324/haematol.2008.002436) | Abstract References ORCID License | 241.50 | 259 |
| 50 | Minimal residual disease prior to allogeneic hematopoietic c… (10.3324/haematol.2016.159343) | Abstract References ORCID License | 241.50 | 259 |